Posted on 6月 28, 20246/28/24
European Parliament’s Revision of the General Pharmaceutical Legislation
Posted on 6月 3, 20246/3/24
Updated Guidance May Ease MDR Transition for SaMD Manufacturers
Posted on 2月 26, 20242/26/24
Q&A: Enhanced Protection and Consistency for PRCI in Canada
Posted on 8月 22, 20238/22/23
The Rising Demand for Light Medical Aesthetic in China
Posted on 8月 1, 20238/1/23
Commercial Key Success Factors (KSFs) for Global Drug Development Programs
Posted on 6月 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on 6月 5, 20236/5/23
Significance of Promotional and Non-Promotional Materials Review Support Services
Posted on 4月 28, 20234/28/23